Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-051542

President, R&D sold 976 shares at $22.73 ($22,184)

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-27 Sale : show line 1 in the form −976 $22.73 $22,184 88,683 D
Open-market sales · 976 sh · avg $22.73 · $22,184
Loading xslF345X03/doc4.xml…